Author

Josefina Carlos

Observed names: Carlos, Josefina, J Carlos, Josefina C. Carlos, Josefina Cadorna Carlos

Institution: University of the East Ramon Magsaysay Memorial Medical Center

Observed institutions: University of the East, University of the East Ramon Magsaysay Memorial Medical Center

ORCID: 0000-0002-2680-4918

Observed ORCID: 0000-0002-2680-4918

OpenAlex ID: A5029682687

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

2016 · Ray Borrow, Pedro Alarcón, et al. · Expert Review of Vaccines · 287

PDF

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

2018 · Reinaldo Acevedo, Xilian Bai, et al. · Expert Review of Vaccines · 207

PDF

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

2022 · Lulu Bravo, Igor Smolenov, et al. · The Lancet · 105

PDF

Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative

2020 · Aye Mya Min Aye, Xilian Bai, et al. · Journal of Infection · 89

PDF

The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth.

1998 · L Bravo, J Carlos, et al. · PubMed · 22

Cost-Effectiveness Analysis of Pneumococcal Vaccination with the Pneumococcal Polysaccharide NTHi Protein D Conjugate Vaccine in the Philippines

2014 · Xu-Hao Zhang, Maria Carmen Nievera, et al. · Value in Health Regional Issues · 21

Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study

2020 · Maria Rosario Capeding, Grace Devota Gomez-Go, et al. · The Journal of Infectious Diseases · 19

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age

2019 · Lulu C. Bravo, Josefina C. Carlos, et al. · Vaccine · 15

PDF

Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study

2023 · Erik Buntinx, Leonardo Brochado, et al. · Vaccine · 14

Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines

2022 · Birkneh Tilahun Tadesse, Lulu Bravo, et al. · Clinical Infectious Diseases · 11

PDF

Invasive meningococcal disease in Malaysia, Philippines, Thailand, and Vietnam: An Asia-Pacific expert group perspective on current epidemiology and vaccination policies

2022 · Usa Thisyakorn, Josefina Carlos, et al. · Human Vaccines & Immunotherapeutics · 8

Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents

2023 · Pio Lopez, Lulu Bravo, et al. · Human Vaccines & Immunotherapeutics · 7

PDF

Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines

2024 · Josefina C. Carlos, Vinna Marie T. Quinones, et al. · Infectious Diseases and Therapy · 6

PDF

A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age

2022 · Josefina Cadorna Carlos, Birkneh Tilahun Tadesse, et al. · The Lancet Regional Health - Western Pacific · 3

PDF

Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: A cluster randomised analysis

2024 · Asma Binte Aziz, Jonathan Dewing Sugimoto, et al. · Journal of Infection · 2

PDF

Safety and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine as a booster against SARS-CoV-2: a phase II, open-label, randomized, double-blinded study

2024 · Renan James Lim, Xiangyan Qiu, et al. · Clinical and Experimental Vaccine Research · 1

PDF

Letter to the Editor Regarding: “Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants”

2022 · Jorge A. Gomez, Javier Nieto Guevara, et al. · Infectious Diseases and Therapy

PDF

Works count: 18

Citation count: 817

H-index: 10

I10-index: 10